Evidence map›Paper›PMID 35808955›Full record

ReviewJournal of sleep research2022

Restless legs syndrome: Over 50 years of European contribution.

Samson G Khachatryan, Raffaele Ferri, Stephany Fulda, Diego Garcia-Borreguero, Mauro Manconi, Maria-Lucia Muntean, Ambra Stefani

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of sleep research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Unfolding the role of exercise in the management of sleep disorders.European journal of applied physiology · 2024
    Review
  14. Article
  15. Restless leg syndrome as a complication of primary hyperparathyroidism: insights from a retrospective study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Restless Legs Syndrome in Parkinson's Disease.Journal of personalized medicine · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 6 countries.

Samson G KhachatryanDepartment of Neurology and Neurosurgery, National Institute of Health, Yerevan, Armenia.ORCID 0000-0002-3098-2135
Raffaele FerriOasi Research Institute IRCCS, Troina, Italy.ORCID 0000-0001-6937-3065
Stephany FuldaSleep Medicine Unit, Neurocenter of Southern Switzerland, Ospedale Civico, Lugano, Switzerland.ORCID 0000-0001-8416-2610
Diego Garcia-BorregueroInternational Sleep Institute, Madrid, Spain.
Mauro ManconiSleep Medicine Unit, Neurocenter of Southern Switzerland, Ospedale Civico, Lugano, Switzerland.ORCID 0000-0002-1849-7196
Maria-Lucia MunteanCenter for Parkinson's Disease and Movement Disorders, Paracelsus-Elena Klinik, Kassel, Germany.
Ambra StefaniSleep Disorders Clinic, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-4259-8824
Innsbruck Medical University · ATNational Institute of Health · AMOasi Maria SS · ITOspedale regionale di Lugano · CHParacelsus Elena Klinik Kassel · DESleep Research Society · USUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Restless legs syndrome (RLS) is a sensorimotor neurological disorder characterised by an urge to move the limbs with a circadian pattern (occurring in the evening/at night), more prominent at rest, and relieved with movements. RLS is one of the most prevalent sleep disorders, occurring in 5%-10% of the European population. Thomas Willis first described RLS clinical cases already in the 17th century, and Karl-Axel Ekbom described the disease as a modern clinical entity in the 20th century. Despite variable severity, RLS can markedly affect sleep (partly through the presence of periodic leg movements) and quality of life, with a relevant socio-economic impact. Thus, its recognition and treatment are essential. However, screening methods present limitations and should be improved. Moreover, available RLS treatment options albeit providing sustained relief to many patients are limited in number. Additionally, the development of augmentation with dopamine agonists represents a major treatment problem. A better understanding of RLS pathomechanisms can bring to light novel treatment possibilities. With emerging new avenues of research in pharmacology, imaging, genetics, and animal models of RLS, this is an interesting and constantly growing field of research. This review will update the reader on the current state of RLS clinical practice and research, with a special focus on the contribution of European researchers.

Indexed as

Restless Legs SyndromeSleep Wake DisordersAnimalsDopamine AgonistsMovementQuality of LifeDopamine AgonistsassessmentaugmentationdiagnosispathogenesisRLStreatment

Identifiers

PMID35808955
PMCPMC9542244
OpenAlexW4284964104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.